Outcome of conservatively treated supraspinatus tendon ruptures in consideration of muscular atrophy rated with contrast-enhanced ultrasound

Not Applicable

Recruiting

Conditions: M75.1
Rotator cuff syndrome

Registration Number: DRKS00016533

Lead Sponsor: niversitätsmedizin Rostock

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 50

Inclusion Criteria

Patients with MRI-assisted diagnosis of supraspinatus tendon rupture and indication for conservative treatment

Exclusion Criteria

•Inability, to understand the essence of this study
•Other rotator cuff defects
•Operations or strong impairment of the contralateral shoulder
•Earlier operations at the effected shoulder
•Tumor
•Infection
•Known intolerance to SonoVue®
•Severe heart failure (NYHA III and IV), Right-Left shunt, uncontrollable hypertension
•Severe lung diseases, ARDS and severe pulmonary arterial hypertension
•Myocardial infarction in the past 14 days
•Age: under 18 years
•Pregnancy or breast-feeding period

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Perfusion of the M. supraspinatus before and after 6 weeks of physiotherapy; measured with CEUS (contrast enhanced ultrasound)

Secondary Outcome Measures

Name	Time	Method
Clinical examination including different scores regarding shoulder function (i.a. ASES, SST, Constant score),<br>Assessment of pain with VAS, power measurement (Isobex); further parameters collected during ultrasound examination.<br><br>All parameters are collected at inclusion and after 6 weeks of standardized treatment with physiotherapy.